Key result
Natriuretic peptides may have an increasing role as prognostic markers and therapeutic targets to assist clinicians in guiding treatment for patients with chronic heart failure.
Why the study?
Does natriuretic peptide-guided treatment improve outcomes in patients with chronic heart failure?
Does natriuretic peptide-guided treatment improve outcomes in patients with chronic heart failure?
Natriuretic peptides may be useful as a prognostic marker and for targeting treatment in chronic heart failure.
May support natriuretic peptide use for prognosis and targeting in chronic HF; leaves open whether guided therapy improves outcomes.
Natriuretic peptides may have an increasing role in assisting clinicians to target treatment in patients with chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Gary A. Wright (2005) studied this question. Natriuretic peptides may have an increasing role as prognostic markers and therapeutic targets to assist clinicians in guiding treatment for patients with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: